Form 8-K - Current report:
SEC Accession No. 0000950170-21-001371
Filing Date
2021-08-12
Accepted
2021-08-12 16:18:40
Documents
13
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20210812.htm   iXBRL 8-K 49625
2 EX-99.1 acet-20210812ex99_1.htm EX-99.1 138133
  Complete submission text file 0000950170-21-001371.txt   327097

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20210812_pre.xml EX-101.PRE 11654
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20210812_lab.xml EX-101.LAB 19266
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20210812.xsd EX-101.SCH 2449
6 EXTRACTED XBRL INSTANCE DOCUMENT acet-20210812_htm.xml XML 4885
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 211167834
SIC: 2834 Pharmaceutical Preparations